Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : CEPH -- Ignore unavailable to you. Want to Upgrade?

To: mcbride who wrote (855)	1/25/1999 1:05:00 PM
From: bluejeans	Respond to of 998

it will be on powerlunch (CNBC) in a few minutes.

To: mcbride who wrote (855)	1/25/1999 2:05:00 PM
From: LLCF	Read Replies (1) \| Respond to of 998

Stock sold off immediately when they even MENTIONED Myotrophin! ha ha ha... CEO refuses to speculate on annual sales number for Provigil, says company will continue trials to expand uses of the drug...(sleep apnia?) quotes nat'l sleep foundation on numbers of people with sleep disorders (60 mill, 11 mill. severe), says drug has big potential beyone Narcolepsy. Says he expects Provigil will make the company profitable in the next couple of years. Closed with "Myotrophin not dead"... at which point the stock sold off. DAK